Public Meeting on Patient Focused Drug Development for Sickle Cell Disease Part 1 Published 2021-06-15 Download video MP4 360p Recommendations 2:26:13 Public Meeting on Patient Focused Drug Development for Sickle Cell Disease Part 2 02:03 Measles, Drug Shortages, AI at FDA, and New Rare Disease Treatments | FDA In Your Day - Ep. 1 01:00 Measles, Drug Shortages, AI at FDA, and New Treatments - FDA In Your Day full video is available now 00:31 Biosimilar medications: As identical twins explain, biosimilars have the same benefits (30 sec.) 00:53 ¡Ten cuidado y conoce los #DatosDeLaFDA! Algunos productos de CBD se venden con afirmaciones... 01:41 GMOs, Farm to Table (Navajo) 00:45 Some CBD products are being sold with unproven claims saying they can treat or prevent diseases 00:46 Agricultural Biotechnology: What Kinds of Genetic Modifications Are There For Crops? (Navajo) 00:33 La FDA es responsable de proteger la salud pública #datosdelaFDA 00:37 Agricultural Biotechnology: How Are GMO Plants Made? (Navajo) 00:40 Agricultural Biotechnology: What GMO Crops are Grown and Sold? (Navajo) 00:42 Why Do We Have GMOs (Navajo) 00:31 Gemelas idénticas explican cómo los medicamentos biosimilares tienen los mismos beneficios (30 seg.) 00:16 Biosimilar medications: As identical twins explain, biosimilars have the same benefits (15 sec.) 00:37 Agricultural Biotechnology: Is it Called GMO or Something Else? (Navajo) 00:16 Gemelas idénticas explican cómo los medicamentos biosimilares tienen los mismos beneficios (15 seg.) Similar videos 1:58:05 Public Meeting: Patient-Focused Drug Development for Fibromyalgia (Part 1 of 2) 2:08:17 Public Meeting: Patient-Focused Drug Development for Opioid Use Disorder - Part 1 1:39:37 Public Meeting on Patient Focused Drug Development for Lung Cancer Part 1 2:44:46 Public Meeting: Patient-Focused Drug Development for Hemophilia A, B, & Other Bleeding Disorders 1 1:54:32 Public Meeting: Patient-Focused Drug Development for Autism (Part 1 of 2) 1:55:30 Public Meeting on Patient Focused Drug Development for Pulmonary Arterial Hypertension Part 1 1:56:32 Public Meeting on Patient Focused Drug Development for Idiopathic Pulmonary Fibrosis Part 1 2:12:12 An introduction to sickle cell disease & thalassaemia in Children 2022 Pt 1 1:39:03 Public Meeting on Patient Focused Drug Development for Pulmonary Arterial Hypertension Part 2 1:00:23 CRISPR Genome Editing for Sickle Cell Disease Therapies – Dr. Shengdar Tsai 1:25:05 Pain Management Task Force (PMTF) | Sept. 2018 | Day 1, Pt. 4: Subcommittee 56:59 Serving the Sickle Cell Disease Community Here and Abroad 17:53 MEDIA CALL: FDA Approves First Gene Therapies to Treat Sickle Cell Disease – 12/08/2023 55:00 Panel Discussion (Building Racial Equity into the Drug Development System) | Kaiser Permanente 1:01:11 Improving the Lives of People with Sickle Cell Disease 1:30:09 Making the Cut | Session 2: Cardiovascular Disease and Sickle Cell Anemia || Radcliffe Institute 1:49:06 ICER CTAF Public Meeting on Sickle Cell Disease (SCD): Policy Roundtable More results